Welcome to Rational Drug Design,
the homepage for Dahlia Weiss.

I am currently a researcher at at Bristol-Myers-Squibb in Redwood City, CA. My main area of focus is Computer Aided Drug Design for Targeted Protein Degradation.

Previously I worked as a scientist at Nurix Therapeutics in San Francisco, designing small molecules to control protein fate through degradation, and at Heptares Therapeutics UK applying CADD for GPCR targets.

I was a postdoc in Brian Schoichet's group at University of California, San Francisco, and completed my doctoral studies as a SimBios fellow in Michael Levitt's group at Stanford University.

Click on the links above to find out more about me.
Thank you for visiting!